While consumers must buy coverage or face penalties under the individual mandate for now, there is speculation that a Trump tax plan could remove this feature of the Affordable Care Act.
For Americans weighing the cost of buying health coverage versus going without, the changing math of 2018 makes the choice easier: 54% of those uninsured and eligible for plans under the Affordable Care Act (ACA) could buy one for less than the penalty they’d pay to go without coverage.
What’s more, among the 5.8 million in this group, about 4.5 million—or 42% of all Americans eligible for ACA coverage who lack it today—could get a bronze plan for free, once they take income-related premium tax credits, according to a new analysis from the Kaiser Family Foundation.
How could this be? It goes back to President Donald Trump’s decision to cancel cost-sharing reductions, the payments to insurers that help them meet ACA requirements for offering low-cost coverage to the poorest Americans.
Trump’s move, coming late as it did on October 12, forced state regulators to load the effects of the lost subsidy onto the cost of silver plans, driving up their cost for Americans who don’t qualify for premium tax credits. Because these credits are calculated as a percentage of premium costs, rising premiums meant rising credits, too. This has led to some oddities in the premiums, with some gold plans with better coverage costing less than some silver plans, along with the quirk of some bronze plans being essentially free for those at the lowest income levels.
The flip side, of course, is that those at the other end of the income scale are being charged much more. For these consumers, the cost-benefit analysis of going without coverage could look quite different. Only 2% of uninsured, market-eligible consumers who don’t qualify for a subsidy can pay less for ACA coverage than they would owe for a penalty next year, the Kaiser analysis found.
The ACA’s many elements—subsidized coverage, Medicaid expansion, and the threat of penalties if one lacks coverage—combined to drive uninsured levels to record lows in 2016. However, a recent Gallup survey found that uninsured levels crept back up over the past year, rising to 12.3% in the third quarter of 2017, the highest it had been since it was 12.9% in the fourth quarter of 2014.
The future of the individual mandate is uncertain. There is speculation it could be canceled as part of a tax plan being weighed in Congress. A report from the Congressional Budget Office released this week found that canceling the mandate would reduce the federal deficit by about $338 billion from 2018 to 2027, but also cause 13 million people to lose coverage and premiums to rise 10% in most years through 2027.
However, there are signs that Americans are aware of this year’s shorter sign-up window for ACA coverage or that the quirks in the premium schedules are attracting lower-income consumers. The Hill reports that 600,000 people signed up for ACA coverage in the first 4 days of open enrollment. This occurred despite HHS cuts to budgets for advertising and navigators; instead, many private insurers have deployed their own teams of helpers to aid consumers.
Open enrollment is only 6 weeks long this year, ending December 15, 2017.
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Study Links COVID-19 Pandemic to Rise in Neoadjuvant Chemotherapy for Ovarian Cancer in US
April 17th 2024There was greater use of neoadjuvant chemotherapy among US patients with ovarian cancer (OC) during the COVID-19 pandemic to reduce potential COVID-19 exposure and cancer treatment-related complications.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen